HIPAA Training for Genetic Testing Lab Client Services Teams

Client services teams handle sensitive information at many points in a genetic testing workflow—from test orders and specimen status calls to result delivery and patient requests. Training should help you recognize protected health information (PHI), verify who is asking, share only when permitted, and promptly escalate concerns under your organization’s procedures.

What counts as PHI in genetic testing workflows?

Genetic information is PHI when it identifies an individual and is maintained by a HIPAA covered entity or business associate. In a lab workflow, that can include a test order, specimen or accession details linked to a person, test status, results, and communications about a specific patient. HHS guidance on genetic information and the HIPAA Privacy Rule explains that genetic information must be individually identifiable and held by a covered entity to qualify as PHI.

Identifiers can appear alongside genetic information in less obvious places: a voicemail, email subject line, portal message, printed label, billing record, or conversation at a service counter. Treat information as PHI when it connects an individual to their health care or test, and follow your lab’s policies for identifying and handling it.

HIPAA applies to covered entities and business associates, not automatically to every organization that handles genetic information. A lab’s legal role depends on its activities and relationships. HHS guidance on covered entities and business associates describes which organizations fall under the HIPAA Rules.

How should client services staff verify test requestors and result recipients?

Before discussing or sending patient-specific information, follow your organization’s verification procedures to confirm both the person’s identity and their authority to receive the information. HIPAA requires reasonable verification when identity or authority is not already known, but generally does not prescribe one universal verification method. HHS guidance on verification of identity and authority explains this flexible standard.

Use approved contact details and systems to check a requestor’s connection to the order. For example, verify a clinician against the lab’s authorized ordering-provider records and a portal user through the approved account process. If a caller’s identity, role, or authority is unclear, pause and use your escalation process rather than relying on familiarity, urgency, or caller-provided details alone.

For a result recipient who is not the ordering clinician or patient, check for the appropriate legal authority, such as a valid patient authorization or verified personal-representative status, as applicable. Record the verification and follow your lab’s procedures for documenting and routing the disclosure.

Which HIPAA rules govern uses and disclosures of genetic test information?

The HIPAA Privacy Rule governs when covered entities may use or disclose PHI and establishes individual rights, including access to information in a designated record set. The HIPAA Security Rule applies to electronic PHI and requires administrative, physical, and technical safeguards. The Breach Notification Rule addresses notification after certain breaches of unsecured PHI. HHS’s Privacy Rule summary and HHS’s Security Rule summary describe these protections.

The Privacy Rule generally allows uses and disclosures for treatment, payment, and health care operations, as well as certain other uses permitted or required by law. A valid patient authorization is generally needed for uses or disclosures that are not otherwise permitted or required. Do not assume that every disclosure requires written authorization—or that a request from a health care professional automatically permits every type of disclosure. Follow the lab’s approved workflow and ask the privacy officer when the purpose or authority is uncertain.

A business associate agreement (BAA) is required when a vendor or other party is acting as a business associate and the HIPAA rules require a written arrangement. Not every exchange between organizations requires a BAA; for example, HHS explains that a provider generally does not need one with a lab for a treatment-related disclosure. HHS guidance on business associates explains the agreement requirements and relevant exceptions.

How can staff apply minimum necessary access and disclosure?

When the minimum necessary standard applies, the Privacy Rule requires reasonable efforts to limit PHI used, disclosed, or requested to what is needed for the purpose. For routine requests, approved procedures can define the appropriate information; unusual requests may need individual review. HHS minimum necessary guidance explains how covered entities should develop policies and procedures.

The standard has important exceptions. It does not apply, for example, to disclosures to the individual who is the subject of the information, disclosures made pursuant to an authorization, or disclosures to or requests by a health care provider for treatment. Staff should follow the lab’s procedures to identify which rule applies rather than using “minimum necessary” as a reason to delay or deny an otherwise permitted disclosure.

For internal access, use only the records and systems needed for your job. Workforce role-based access helps limit access according to job responsibilities, while approved scripts and workflows can help staff provide only the information relevant to a particular inquiry.

What safeguards protect PHI across phone, email, portals, and paper records?

On phone calls, verify the caller before discussing a patient’s order or results. Speak discreetly, avoid discussing patient details where others can overhear, and follow policy before leaving a voicemail. If the caller requests information that is outside your role or the approved workflow, refer the request to the appropriate team.

Email is not categorically prohibited for electronic PHI, but it must be protected under the Security Rule. Use approved email and file-transfer tools, confirm recipient addresses, and apply the safeguards required by your organization. HHS explains that email can be used when electronic PHI is adequately protected, and that encryption is an addressable implementation specification requiring an appropriate assessment and documented decision—not a universal standalone mandate in every circumstance. HHS guidance on email and electronic PHI and HHS guidance on encryption provide details.

For portals, use approved accounts, protect credentials, and follow procedures for access changes or suspected account compromise. For paper records, keep documents out of public view, retrieve printouts promptly, and store or dispose of them using approved safeguards. The HIPAA Security Rule also calls for access controls, audit controls, authentication, and transmission security for electronic systems. HHS’s Security Rule overview outlines these safeguards.

How should staff handle individual requests for genetic test reports?

Route a patient’s request through the lab’s established access process. If the lab is a covered entity, individuals generally have a right to access PHI about themselves in a designated record set. HHS specifically explains that a covered clinical laboratory must provide access, upon request, to genetic test reports and, where included in the designated record set, underlying information generated by the test. HHS guidance on access to laboratory and genomic information explains this right.

Verify the requester’s identity and, if someone is acting for the patient, their authority. Send the request to the designated privacy, health information management, or access team; do not make an informal decision to withhold or release a report. HIPAA generally requires a covered entity to act on an access request within 30 calendar days. A permitted extension may provide up to 30 additional days if the entity gives the individual a written explanation and completion date within the initial period.

HIPAA does not require written authorization for a disclosure made directly to the individual under the right of access. A request to send records to a third party may have separate requirements, so use the designated process to confirm the request and recipient before releasing information.

What should staff do after suspected unauthorized access or disclosure?

Report a suspected misdirected email, unauthorized portal access, overheard disclosure, missing paper record, or other privacy or security concern promptly through your organization’s incident-reporting process. Notify the designated privacy or security contact, preserve relevant messages or other evidence as instructed, and share facts through approved channels. Do not delete records, investigate on your own beyond your role, or promise that no notification will be required.

The covered entity or business associate is responsible for assessing whether an incident is a breach and determining any required notifications. Under the Breach Notification Rule, an impermissible use or disclosure of unsecured PHI is generally presumed to be a breach unless an exception applies or a risk assessment demonstrates a low probability that the PHI was compromised. Required notifications must be made without unreasonable delay and, in applicable cases, no later than 60 days after discovery. A business associate must notify the covered entity, and its BAA may require faster reporting. HHS’s Breach Notification Rule guidance explains the assessment and notification requirements.

Effective training puts these steps into practice: recognize identifiable genetic information, verify identity and authority, use role-appropriate access, follow approved disclosure and access workflows, and report suspected incidents promptly.

FAQs.

Is a genetic test order considered PHI under HIPAA?

It can be. When an order identifies an individual and is maintained by a HIPAA covered entity or business associate, it is individually identifiable health information and may be PHI. HHS guidance on genetic information explains how HIPAA’s PHI definition applies.

Can client services staff release results directly to a patient?

A covered clinical laboratory generally must provide an individual access to PHI in its designated record set upon request, subject to applicable exceptions and procedures. Staff should verify the patient’s identity and route the request through the lab’s established access process rather than independently deciding how to release a report.

Who is authorized to receive genetic test results?

Depending on the circumstances, recipients may include the patient, a verified personal representative, an authorized health care provider, or another recipient when disclosure is permitted by law or supported by a valid authorization. Verify the recipient’s identity and authority and follow the lab’s policies before disclosing results.

Does HIPAA require written authorization to disclose genetic information?

No—not for every disclosure. HIPAA permits certain disclosures without authorization, including many disclosures for treatment, payment, and health care operations, as well as disclosures to the individual under the access right. A written authorization is generally required when a use or disclosure is not otherwise permitted or required by the Privacy Rule.